List view / Grid view

Viruses

Global alliance to end childhood AIDS

3 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

New global alliance launched by UNAIDS, UNICEF and WHO aims to overcome “outrageous” disparities in the AIDS response and ultimately end AIDS in children by 2030.

article

Developing broad-spectrum vaccines that target the heart of mutating viruses

3 August 2022 | By Alexandre Le Vert (Osivax)

Alexandre Le Vert, CEO and Co-Founder of Osivax, explores some evolving approaches to vaccine development that aim to counter the effects of virus mutation.

blue gloved hand holding a vial labelled 'Influenza Vaccine'

news

GSK to supply Europe with 85mn pandemic flu vaccines

2 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

New agreement reserves million doses of GSK’s pandemic influenza vaccine Adjupanrix to support Europe’s pandemic preparedness.

Doctor injecting a patient in the upper arm using a syringe

news

ViiV agrees to expand access to long-acting HIV PrEP

1 August 2022 | By Hannah Balfour (European Pharmaceutical Review)

Under a new agreement, licenced manufacturers will be able to supply generic versions of ViiV’s long-acting cabotegravir HIV pre-exposure prophylaxis (PrEP) medication to developing nations.

3D illustration of Nipah virus particles - Nipah virus is a newly emerging bat-borne virus that causes acute respiratory illness and severe encephalitis

news

Nipah virus vaccine enters Phase I trial

13 July 2022 | By Hannah Balfour (European Pharmaceutical Review)

The investigational mRNA-1215 vaccine developed to prevent Nipah virus – a bat-borne disease of pandemic potential, will be evaluated for safety, tolerability and immunogenicity.

article

Anatomy of a ‘correlate of protection’ for T-cell vaccines

28 June 2022 | By Thomas Rademacher (Emergex Vaccines)

The use of proprietary vaccine constructs to prime naive CD8+ T-cells via skin dendritic cells and thus enable induction of targeted cellular immunity, establishing tissue-resident CD8+ T-memory cells, is a new vaccination strategy being explored at Emergex Vaccines. Here, Professor Thomas Rademacher, Emeritus Professor of Molecular Medicine – UCL and…

Investment in pharmaceutical/drug development concept - cartoon of laboratory researchers recieving funding for work

news

Healthier Together and philanthropic ventures in tropical disease

27 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

Europe launches the EU Non-communicable diseases (NCDs) initiative, while GSK and Novartis promise millions to support drug R&D for neglected tropical diseases and malaria.

close up of person's hand sliding a wooden puzzle block with people icons on it into a space in a larger puzzle - idea of appointments or recruitment

article

Pharmaceutical C-suite update

21 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

With two knighthoods in the last month, here EPR discusses five developments in the drug development community’s C-suite.

news

WTO waives intellectual property rights for COVID-19 vaccines

17 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

According to IFPMA, the World Trade Organization decision to waive intellectual property rights for COVID-19 vaccines fails to tackle the biggest barrier to access: trade.

news

Bavarian Nordic to supply EU Member States with monkeypox vaccine

15 June 2022 | By Mandy Parrett (European Pharmaceutical Review)

Bavarian Nordic has announced it will supply 110,000 doses of its MVA-BN smallpox/monkeypox vaccine to the European Health Emergency Preparedness and Response Authority (HERA) over the coming months.

COVID-19 Vaccine vial and syringe for injection

news

EMA’s first critical medicines list for COVID-19

9 June 2022 | By Hannah Balfour (European Pharmaceutical Review)

The approved COVID-19 vaccines and treatments on the list will be monitored to prevent and mitigate the impact of shortages.

antibodies attacking an orange coronavirus particle

news

AstraZeneca’s Evusheld significantly reduces risk of developing severe COVID-19

8 June 2022 | By Mandy Parrett (European Pharmaceutical Review)

AstraZeneca's Evusheld (tixagevimab and cilgavimab) provided clinically and statistically significant protection against progression to severe COVID-19 over placebo.

news

Retrospective UK study offers insight into monkeypox

31 May 2022 | By Mandy Parrett (European Pharmaceutical Review)

Following the recent spate of monkeypox cases across Europe and North America, The Lancet has published insights from a study of seven UK monkeypox cases between 2018 and 2021.

news

AstraZeneca acquires rights to develop mAbs against COVID-19

20 May 2022 | By European Pharmaceutical Review

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2.

Close up of an Aedes Aegypti Mosquito on human skin - idea of mosquito-borne viruses

news

WEVEE vaccine shows promise against trio of rare but deadly viruses

16 May 2022 | By Hannah Balfour (European Pharmaceutical Review)

Phase I trial data suggests that a vaccine targeting three mosquito-borne encephalitis viruses is safe and can elicit an immune response.

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Viruses